By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


AVANIR Pharmaceuticals 

11388 Sorrento Valley Road

San Diego  California  92121  U.S.A.
Phone: 858-622-5200 Fax: 858-658-7447




Company News
AVANIR Pharmaceuticals (AVNR) Announces Multiple Data Presentations Highlighting Its Central Nervous System (CNS) Therapeutics Franchise At The American Academy of Neurology 2015 Annual Meeting 4/15/2015 10:34:06 AM
AVANIR Pharmaceuticals (AVNR) Release: Through Laughter And Tears Comes First-Ever Documentary About Life With Pseudobulbar Affect (PBA) 12/9/2014 9:30:53 AM
AVANIR Pharmaceuticals (AVNR) Cancels Previously Scheduled Earnings Call 12/8/2014 7:28:00 AM
AVANIR Pharmaceuticals (AVNR) Announces Date Of Fiscal 2014 Fourth Quarter Financial Results And Conference Call 12/2/2014 11:48:10 AM
Otsuka Pharmaceutical Co., Ltd. Buys AVANIR Pharmaceuticals (AVNR) For $3.5 Billion 12/2/2014 6:21:23 AM
AVANIR Pharmaceuticals (AVNR) Receives Complete Response Letter (CRL) From FDA On AVP-825 NDA 12/1/2014 9:15:10 AM
AVANIR Pharmaceuticals (AVNR) Making Strides With Alzheimer’s Drug, Says Analyst 11/24/2014 2:04:45 PM
AVANIR Pharmaceuticals (AVNR) To Participate In Two Conferences In December 11/20/2014 12:29:41 PM
AVANIR Pharmaceuticals (AVNR)'s Migraine Treatment Will Unlikely Win Approval By Scheduled Timeline 11/7/2014 8:31:20 AM
AVANIR Pharmaceuticals (AVNR) Announces Publication Of Pivotal Phase 3 Results From AVP-825 Acute Migraine Study In The Journal "Headache" 10/31/2014 7:26:20 AM